Tekla Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$29.3M Sell
458,498
-205,298
-31% -$13.8M 1.15% 23
2023
Q1
$46M Sell
663,796
-23,733
-3% -$1.67M 1.75% 19
2022
Q4
$49.5M Sell
687,529
-191,947
-22% -$14.5M 1.87% 17
2022
Q3
$62.5M Buy
879,476
+96,741
+12% +$7.02M 2.56% 11
2022
Q2
$60.3M Buy
782,735
+58,859
+8% +$4.48M 2.37% 11
2022
Q1
$52.9M Sell
723,876
-23,167
-3% -$1.56M 1.86% 18
2021
Q4
$46.6M Buy
747,043
+134,807
+22% +$7.91M 1.5% 22
2021
Q3
$36.2M Sell
612,236
-43,737
-7% -$2.88M 1.17% 25
2021
Q2
$43.8M Sell
655,973
-236,480
-26% -$15.4M 1.42% 18
2021
Q1
$56.3M Sell
892,453
-97,455
-10% -$6.06M 1.94% 15
2020
Q4
$61.4M Buy
989,908
+44,768
+5% +$2.75M 2.16% 11
2020
Q3
$57M Sell
945,140
-32,365
-3% -$1.95M 2.14% 13
2020
Q2
$57.5M Buy
977,505
+132,573
+16% +$7.93M 2.19% 10
2020
Q1
$47.1M Buy
844,932
+70,070
+9% +$4.28M 2.13% 11
2019
Q4
$49.7M Buy
774,862
+36,818
+5% +$2.11M 1.88% 12
2019
Q3
$37.4M Hold
738,044
1.63% 14
2019
Q2
$33.5M Hold
738,044
1.37% 17
2019
Q1
$35.2M Buy
738,044
+85,078
+13% +$4.24M 1.43% 19
2018
Q4
$33.9M Buy
652,966
+286,902
+78% +$15.4M 1.45% 19
2018
Q3
$22.7M Sell
366,064
-284,966
-44% -$16.9M 0.82% 32
2018
Q2
$36M Buy
651,030
+125,308
+24% +$6.77M 1.37% 19
2018
Q1
$33.3M Buy
525,722
+176,601
+51% +$11.4M 1.29% 20
2017
Q4
$21.4M Buy
+349,121
New +$21.8M 0.83% 29
2017
Q3
Sell
-186,500
Closed -$10.4M 153
2017
Q2
$10.4M Hold
186,500
0.39% 58
2017
Q1
$10.1M Buy
+186,500
New +$10.2M 0.39% 57
2016
Q2
Sell
-202,600
Closed -$12.9M 158
2016
Q1
$12.9M Hold
202,600
0.55% 43
2015
Q4
$13.9M Sell
202,600
-332,640
-62% -$22M 0.51% 42
2015
Q3
$31.7M Hold
535,240
1.14% 21
2015
Q2
$35.6M Hold
535,240
1.29% 19
2015
Q1
$34.5M Hold
535,240
1.37% 20
2014
Q4
$31.6M Hold
535,240
1.48% 18
2014
Q3
$27.4M Buy
535,240
+332,640
+164% +$16.6M 1.28% 23
2014
Q2
$9.83M Buy
+202,600
New +$9.98M 0.9% 33

Other funds holding BMY